Haberey; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Haberey; Martin.The latest application filed is for "novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors".

Company Profile

0.31.35

Haberey; Martin - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Anthranilamide Pyridinureas As Vascular Endothelial Growth Factor (vegf) Receptor Kinase Inhibitors App 20110124680 - BOHLMANN; Rolf ; et al.	2011-05-26
Aza- and polyazanthranyl amides and their use as medicaments App 20110071165 - SEIDELMANN; Dieter ; et al.	2011-03-24
Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Grant 7,906,533 - Bohlmann , et al. March 15, 2	2011-03-15
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Grant 7,902,229 - Bohlmann , et al. March 8, 2	2011-03-08
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines Grant 7,615,565 - Huth , et al. November 10, 2	2009-11-10
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Grant 7,572,794 - Bohlmann , et al. August 11, 2	2009-08-11
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines Grant 7,517,894 - Huth , et al. April 14, 2	2009-04-14
Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors Grant 7,479,491 - Seidelmann , et al. January 20, 2	2009-01-20
N-oxide anthranylamide derivatives and their use as medicaments Grant 7,459,470 - Ernst , et al. December 2, 2	2008-12-02
Cyanoanthranilamide derivatives and the use thereof as medicaments Grant 7,429,592 - Ernst , et al. September 30, 2	2008-09-30
Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones App 20070135489 - Huth; Andreas ; et al.	2007-06-14
Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments Grant 7,211,680 - Steinmeyer , et al. May 1, 2	2007-05-01
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones Grant 7,202,260 - Huth , et al. April 10, 2	2007-04-10
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines App 20070015794 - Huth; Andreas ; et al.	2007-01-18
Aza- and polyazanthranyl amides and their use as medicaments App 20060287339 - Seidelmann; Dieter ; et al.	2006-12-21
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines Grant 7,148,357 - Huth , et al. December 12, 2	2006-12-12
Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors App 20060264425 - Bohlmann; Rolf ; et al.	2006-11-23
Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents Grant 7,115,758 - Steinmeyer , et al. October 3, 2	2006-10-03
Ortho-substituted anthranilic acid amides and their use as medicaments Grant 7,081,468 - Krueger , et al. July 25, 2	2006-07-25
Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors App 20060160861 - Bohlmann; Rolf ; et al.	2006-07-20
Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors App 20060116380 - Bohlmann; Rolf ; et al.	2006-06-01
N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20060074112 - Altmann; Karl-Heinz ; et al.	2006-04-06
Anthranyl amides and their use as medicaments Grant 7,012,081 - Krueger , et al. March 14, 2	2006-03-14
N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF Grant 7,002,022 - Altmann , et al. February 21, 2	2006-02-21
Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents App 20060014747 - Krueger; Martin ; et al.	2006-01-19
Anthranilamides and their use as pharmaceutical agents App 20050261343 - Krueger, Martin ; et al.	2005-11-24
Verification of translation App 20050227951 - Steinmeyer, Andreas ; et al.	2005-10-13
New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments App 20050080058 - Steinmeyer, Andreas ; et al.	2005-04-14
VEGF receptor tyrosine kinase inhibitors Grant 6,878,720 - Altmann , et al. April 12, 2	2005-04-12
Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors App 20050054692 - Seidelmann, Dieter ; et al.	2005-03-10
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines App 20050054654 - Huth, Andreas ; et al.	2005-03-10
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones App 20050049281 - Huth, Andreas ; et al.	2005-03-03
N-oxide anthranylamide derivatives and their use as medicaments App 20050032816 - Ernst, Alexander ; et al.	2005-02-10
Cyanoanthranilamide derivatives and the use thereof as medicaments App 20040266770 - Ernst, Alexander ; et al.	2004-12-30
Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 App 20040254185 - Ernst, Alexander ; et al.	2004-12-16
Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors Grant 6,818,661 - Seidelmann , et al. November 16, 2	2004-11-16
Aza-and polyazanthranyl amides and their use as medicaments App 20040224968 - Seidelmann, Dieter ; et al.	2004-11-11
N-aryl (THIO) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20040198782 - Altmann, Karl-Heinz ; et al.	2004-10-07
Substituted N-(1,4,5,6,-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents App 20040186156 - Kruger, Martin ; et al.	2004-09-23
Combinations and compositions which interfere with VEGF/ VEGF and angiopoietin/ Tie receptor function and their use (II) App 20040147449 - Siemeister, Gerhard ; et al.	2004-07-29
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines App 20040147535 - Huth, Andreas ; et al.	2004-07-29
Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents Grant 6,747,046 - Kruger , et al. June 8, 2	2004-06-08
Ortho-substituted anthranilic acid amides and their use as medicaments App 20040102441 - Krueger, Martin ; et al.	2004-05-27
Selected anthranilaminde pyridinamides and their use as pharmaceutical agents App 20040039019 - Huth, Andreas ; et al.	2004-02-26
Anthranyl amides and their use as medicaments App 20040029880 - Krueger, Martin ; et al.	2004-02-12
Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents App 20030212121 - Kruger, Martin ; et al.	2003-11-13
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments Grant 6,642,218 - Steinmeyer , et al. November 4, 2	2003-11-04
Anthranylalkyl and cycloalkyl amides and use thereof as vegf receptor inhibitors App 20030176469 - Seidelmann, Dieter ; et al.	2003-09-18
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents Grant 6,613,920 - Steinmeyer , et al. September 2, 2	2003-09-02
New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents App 20030149006 - Steinmeyer, Andreas ; et al.	2003-08-07
Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents Grant 6,603,031 - Steinmeyer , et al. August 5, 2	2003-08-05
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments Grant 6,600,058 - Steinmeyer , et al. July 29, 2	2003-07-29
N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20030064992 - Altmann, Karl-Heinz ; et al.	2003-04-03
Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use App 20030055006 - Siemeister, Gerhard ; et al.	2003-03-20
Vitamin D derivatives with phosphorus atoms in the side chains Grant 6,531,459 - Steinmeyer , et al. March 11, 2	2003-03-11
New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents App 20030018194 - Steinmeyer, Andreas ; et al.	2003-01-23
VEGF receptor tyrosine kinase inhibitors Grant 6,448,277 - Altmann , et al. September 10, 2	2002-09-10
New Vitamin D Derivatives With Carbo-or Heterocyclic Substituents At C-25, A Process For Their Production, Intermediate Products And Their Use For Producing Medicaments App 20020049344 - STEINMEYER, ANDREAS ; et al.	2002-04-25
N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20020019414 - Altmann, Karl-Heinz ; et al.	2002-02-14
Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof Grant 5,700,791 - Steinmeyer , et al. December 23, 1	1997-12-23
20-position modified pharmaceutically active vitamin D series compounds Grant 5,585,368 - Steinmeyer , et al. * December 17, 1	1996-12-17
20-methyl-substituted vitamin D derivatives Grant 5,446,035 - Neef , et al. August 29, 1	1995-08-29
23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agents Grant 5,411,949 - Neef , et al. May 2, 1	1995-05-02
Novel carbacyclins, processes for their preparation and their use as medicinal agents Grant 5,013,758 - Skuballa , et al. May 7, 1	1991-05-07
2,2:6,6-diethylen-3-oxo-17alpha-pregn-4-ene-21,17alpha-carbolactones, process for their production & pharmaceutical preparations containing them Grant 4,868,166 - Bittler , et al. September 19, 1	1989-09-19
Certain prostacyclins and their blood-pressure-lowering and thrombocyte-aggregation-inhibiting compositions and methods Grant 4,532,236 - Nickolson , et al. July 30, 1	1985-07-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.